Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism

European Journal of Pediatrics

Volumn 155, Issue 11, 1996, Pages 921-927

  Nowak Gottl U ^a   Auberger, K ^b   Gobel U ^c   Kreuz, W ^d   Schneppenheim, R ^e   Vielhaber, H ^a   Zenz, W ^f   Zieger, B ^g  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f UNIVERSITY HOSPITAL GRAZ   (Austria)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Childhood thromboembolism; Protein C; Protein S; Resistance to activated protein C (APCR)

Indexed keywords

ACTIVATED PROTEIN C; ANTIVITAMIN K; PROTEIN S;

ANTICOAGULATION; CHILD; CHILDHOOD DISEASE; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CHILD; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMANS; MUTATION; PHENOTYPE; PROTEIN C; PROTEIN C DEFICIENCY; THROMBOEMBOLISM;

EID: 0029851657     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02282879     Document Type: Review

References (83)

1. Alessi MC, Aillaud MF, Paut O, Roquelaure B, Alhenc-Gelas M, Pellissier MC, Ghanen N, Juhan-Vague I (1996) Purpura fulminans in a patient homozygous for a mutation in the protein C gene - prenatal diagnosis in a subsequent pregnancy. Thromb Haemost 75: 520-521
2. Allaart CF, Poort S, Rosendal F, Reitsma P, Bertina R (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341 : 134-138
3. Amer L, Kisiel W, Searles RP, Williams RC Jr (1990) Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thromb Res 57: 247-258
4. Andrew M (1995) Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 74:415-425
5. Andrew M, Paes B, Milner R, Johnston M (1990) Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 12: 95-104
6. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80: 1998-2005
7. Andrew M, David M, Adams M (1993) Venous thromboembolic complications in children. J Pediatr 123:337-346
8. Arav-Bogner R, Reif S, Bujanover Y (1995) Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr 126:586-588
9. Arnout J, Vanrusselt M, Vermylen J (1995) Resistance to activated protein C in a population of patients with antiphospholipid antibodies. Thromb Haemost 73: 1275
10. Auberger K (1992) Evaluation of a new protein C concentrate and comparison of protein C assays in a child with congenital protein C deficiency. Ann Hematol 64: 146-151
11. Baliga V, Thwaites R, Tillyer ML, Minford A, Parapia L, Allgrove J (1995) Homozygous protein C deficiency - management with protein C concentrate. Eur J Pediatr 154:534-535
12. Bandello F, D'Angelo SV, Parlavecchia M, Tavola A, Valle PD, Brancato R, D'Angelo A (1994) Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 72: 39-43
13. Bertina RM, Ploos Van Amstel HK, Wijngaarden A van, Coenen J, Leemhuis MP, Deutz Terlouw PP, Linden IK van der, Reitsma PH (1990) Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 76: 538-548
14. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, Ronde H de, Velden PA van der, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369: 64-67
15. Bick RL, Baker WF (1994) The antiphospholipid and thrombosis syndromes. Med Clin North Am 78: 667-684
16. Bick R, Ucar K (1992) Hypercoagulability and thrombosis. Hematol Oncol Clin North Am 6: 1421-1429
17. Bovill EG, Bauer KA, Dickermann JD, Callas P, West B (1989) The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 73: 712-717
18. Cooper PC, Hampton KK, Makris M, Abuzenadah A, Paul B, Preston FE (1994) Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haematol 88: 201-203
19. Dahlbäck B (1986) Inhibition of protein C cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 261: 12022-12027
20. Dahlbäck B (1991) Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 66: 49-61
21. Dahlbäck B (1995) New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg 506 to Gln mutation in factor V as a pathogenetic risk factor. Thromb Haemost 74: 139-148
22. Dahlbäck B (1995) Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Int Med 237: 221-227
23. Dahlbäck B, Carlsson M (1991) Factor VIII defect associated with familial thrombophilia. Thromb Haemost 65: 658
24. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90: 1004-1008
25. D'Angelo SV, Mazzola G, Valle PD, Testa S, Pattarini E, D'Angelo A (1995) Variable interference of activated protein C resistance in the measurement of protein S activity by commercial assays. Thromb Res 77: 375-378
26. David M, Andrew M (1993) Venous thromboembolic complications in children. J Pediatr 123: 337-346
27. David M, Manco-Johnson M, Andrew M (1995) Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the subcommittee on perinatal haemostasis of the scientific and standardization committee of the ISTH. Thromb Haemost 74:791-792
28. Dreyfuß M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchernia G (1991) Treatment of homozygous protein C deficiency and neonatal purpura fulminans with purified protein C concentrate. N Engl J Med 325: 1565-1568
29. Edenbrandt CM, Lindwall A, Wydro R, Stenflo J (1990) Molecular analysis of the gene for vitamin K-dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 29:7861-7868
30. Esmon CT (1989) The role of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743-4749
31. Faioni EM, Boyer-Neumann C, Franchi F, Wolf M, Meyer D, Mannucci P (1994) Another protein S functional assay is sensitive to resistance to activated protein C. Thromb Haemost 72:643-651
32. Foster DC, Yoshitake S, Davie EW (1985) The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci USA 82:4673-1677
33. Gandrille S, Borgel D, Eschwege-Gufflet V, Aillaud MF, Dreyfuß M, Matheron C, Gaussem P, Abgrall JF, Jude B, Sie P, Toulon P, Aiach M (1995) Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active gene. Blood 85: 130-139
34. Gladson CL, Scharrer I, Hach V, Beck KM, Griffin JH (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59: 18-22
35. Göbel U (1994) Inherited or acquired disorders of blood coagulation in children with neurovascular complications. Neuropediatrics 25:4-7
36. Gomez E, Ledford MR, Pegelow CH, Reitsma PH, Bertina RM (1994) Homozygous protein S deficiency caused by one base pair deletion that leads to a stop codon in exon III of the protein S gene. Thromb Haemost 71:723-726
37. Gurewich V, Pannell R, Louie S, Kelley P, Suddith RL, Greenlee R (1984) Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest 73: 1731-1739
38. Hayashi T, Nishioka J, Shigekiyo T, Saito S, Suzukj K (1994) Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S. Blood 83:683-690
39. Haverkate F, Samama M (1995) Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 73: 151-161
40. Heijboer H, Brandjed D, Buller H, Sturk A, Wouter ten Cate J (1990) Deficiencies of coagulation inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 323: 1512-1516
41. Hirsch J (1991) Oral anticoagulant drugs. N Engl J Med 342: 1865-1875
42. Ichinosc A, Fujikawa K, Suyama T (1986) The activation of prourokinase by plasma kallikrein and ist inactivation by thrombin. J Biol Chem 261 : 3486-3489
43. Jaffe EA (1991) Endothelial structure and function. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ (eds) Hematology, basic principles and practice. Churchill-Livingstone, New York, pp 1198-1213
44. Kluft C (1994) Constitutive synthesis of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1): conditions and therapeutic targets. Fibrinolysis 8(2): 1-7
45. Kodish E, Potter C, Kirschbaum N, Foster P (1995) Activated protein C resistance in a neonate with venous thrombosis. J Pediatr 127:645-648
46. Koster T, Rosendaal FR, Ronde H de, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342: 1503-1506
47. Levy M, Benson L, Burrows PE, Ben tur Y, Strong DK, Smith J, Johnson D, Jacobson S, Koren G (1991) Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 118:467-472
48. Malm J, Laurell M, Nilsson I, Dahlbäck B (1992) Thromboembolic disease - critical evaluation of laboratory investigation. Thromb Haemost 8:7-13
49. Mannucci PM, Tripodi A (1987) Laboratory screening of inherited thrombotic syndromes. Thromb Haemost 57: 247-251
50. Marlar RA, Neumann A (1990) Neonatal purpurn fulminans due to homozygous protein C or S deficiencies. Sem Thromb Hemost 16:299-309
51. Miletich J, Sherman L, Broze G (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317:991-996
52. Müller EM, Ehrenthal W, Hafner G, Schranz D (1996) Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate. Eur J Pediatr 155:20-25
53. Nowak-Göttl U, Schwabe D, Schneider W, Schlösser R, Kreuz W (1992) Thrombolysis with recombinant tissue type plasminogen activator in renal venous thrombosis in infancy. Lancet 340: 1105
54. Nowak-Göttl U, Funk M, Mosch G, Wegerich B, Kornhuber B, Breddin HK (1994) Univariate tolerance regions for fibrinogen, antithrombin III. protein C, protein S, plasminogen and α2-antiplasmin in children using the new automated coagulation laboratory (ACL) method. Klin Pädiatr 206:437-439
55. Nowak-Göttl U, Ashka I, Koch HG, Boos J, Dockhorn-Dworniczak B, Deufel T, Jürgens H, Kohlhase B, Kuhn N, Laupert A, Rath B, Wollt JEA. Schneppenheim R (1995) Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia - the need for a prospective multicentre study. Blood Coag Fibrinol 6:761-764
56. Nowak-Göttl U, Koch HG, Aschka I, Kohlhase B, Vielhaber H, Kurlemann G, Oleszuk-Rasche K, Kehl HG, Jürgens H, Schneppenheim R (1996) Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haemalol 92: 992-998
57. Nowak-Göttl U, Kohlhase B, Vielhaber H, Aschka I, Schneppenheim R, Jürgens H (1996) APC resistance in neonates and infants: adjustment of the aPTT-based method. Thromb Res 81 : 665-670
58. Nuss R, Hys T, Manco-Johnson M (1995) Childhood thrombosis. Pediatrics 96:291-294
59. PetäJä J, Jalanko H, Holmberg C, Kinnunen S, Syrjälä (1995) Resistance to activated protein C as an underlying cause of recurrent venous thrombosis during relapsing nephrotic syndrome. J Pediatr 127:103-105
60. Ploos Van Amstel HK, Zanden AL van der, Bakker E, Reitsma PH, Bertina RM (1987) Two genes homologous with human protein S cDNA are located on chromosome 3. Thromb Haemost 58:982-987
61. Ploos Van Amstel HK, Huisman MV, Reitsma PH, Wouter ten Cate J, Berlina RM (1989) Partial protein S gene deletion in a family with hereditary thrombophilia. Blood 73:479-483
62. Ploos Van Amstel HK, Reitsma PH, Bertina RM (1989) The human protein S locus: identification of the PS alpha gene as a site of liver protein S messenger RNA synthesis. Biochem Biophys Res Commun 157:1033-1038
63. Ploos Van Amstel HK, Reitsma PH, Hamulyak K, Smulders CE de, Mannucci PM, Bertina RM (1989) A mutation in the protein S pseudogene is linked to protein S deficiency in a thrombophilic family. Thromb Haemost 62:897-901
64. Ploos Van Amstel HK, Reitsma PH, Logt CP van der, Bertina RM (1990) Intron-exon organisation of the active human protein S gene PS alpha and its pseudogene PS beta: duplication and silencing during primate evolution. Biochemistry 29:7853-7861
65. Plutzky J, Hoskins JA, Long GL, Crabtree GR (1986) Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 83:546-550
66. Reitsma PH, Poort SR, Allaart CF, Briet E, Bertina RM (1991) The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: Heterogenity and founder effects. Blood 78:890-894
67. Reitsma PH, Ploos Van Amstel HK, Bertina RM (1994) Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 93:486-492
68. Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN (1995) Protein C deficiency: a database of mutations, 1995 update. Thromb Haemost 73:786-879
69. Rodgers L, Luther C. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am J Med 88: 389-395
70. Rosenbaum T, Rammos S, Kniemeyer HW, Göbel U (1993) Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: successful lysis with recombinant tissue type plasminogen activator 2 weeks after onset symptoms. Eur J Pediatr 152:978-980
71. Ryan CA, Andrew M (1992) Failure of thrombolytic therapy in four children with extensive thrombosis. Am J Dis Child 146: 187-193
72. Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL (1991) A 5.3-kb deletion including exon XIII of the protein S a gene occurs in two protein S-deficient families. Blood 77:551-559
73. Schmidt B, Andrew M (1995) Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96:939-943
74. Schwabe D, Schlösser R, Auberger K, Kries R von, Nowak-Göttl U (1996) Thrombolyse mit rt-PA im I. Lebensjahr. Hämostaseologie (in press)
75. Shen L, Dahlbäck B (1994) Factor V and protein C in degradation of factor Villa. J Biol Chem 269: 18735-18738
76. Simioni P, De Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A (1995) Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 26:885-890
77. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis tor venous thrombosis. N Engl J Med 330:517-522
78. Taberno M, Tomas J, Alberca I, Orfao A, Borrasca A, Vincenle V (1991) Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 36: 249-254
79. Uziel Y, Laxer RM, Blaser S, Andrew M, Schneider R, Silverman ED (1995) Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 126:722-727
80. Vielhaber H, Kohlhase B, Kehl HG, Fliedner M, Kececioglu D, Dockhorn-Dwornicvak B, Kehrel B, Veltmann H, Vogt J, Nowak-Göttl U (1996) Flush heparin during cardiac catherisation prevents long-term coagulation activation in children without APC-resistance - preliminary results. Thromb Res 81:651-656
81. Whitlock J, Janco R, Phillips J (1989) Inherited hypercoagulable states in children. Am J Pediatr Hematol Oncol 11:170-173
82. Wiman B, Hamsten A (1990) The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Sem Thromb Haemost 16: 207-214
83. Zenz W, Muntean W, Gallistl S, Leschnik B, Beitzke A (1994) Inherited resistance to activated protein C in a boy with multiple thromboses in early infancy. Eur J Pediatr 154:285-288